|
Public |
|
| Healthcare & Pharmaceuticals - Pharmaceuticals | |
| over $1B | |
| over 10K | |
| www.pfizer.com | |
| (212) 733-2323 | |
| (302) 655-5049 | |
| media@pfizer.com | |
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in discovering, developing and manufacturing of healthcare products. The Company's segments include Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). Its biopharmaceutical products include Lipitor, Sutent and the Premarin family of products. Its biotechnology products include BeneFIX, ReFacto and Xyntha. The Company's contract manufacturing business, Pfizer CentreOne, consists of its contract manufacturing and active pharmaceutical ingredient sales operation, including manufacturing and supply agreements with Zoetis Inc., and Hospira’s One-2-One sterile injectables contract manufacturing operation. Its research focuses on six areas, which include immunology and inflammatio... (Source: SEC reports)
Competitor - 1/7
Which company is more competitive with Pfizer?
Sep 20, 2018 19:18:44
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that its 20-Valent Pneumococcal
Conjugate Vaccine (20vPnC) candidate, PF-06482077, [...]
Sep 20, 2018 17:30:41
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that its 20-Valent Pneumococcal
Conjugate Vaccine (20vPnC) candidate, PF-06482077, [...]
Sep 18, 2018 19:18:48
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that additional sensitivity and
post-hoc analyses from the Tafamidis [...]
Sep 18, 2018 19:12:50
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen
to a [...]
Sep 18, 2018 17:30:47
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that additional sensitivity and
post-hoc analyses from the Tafamidis [...]